EQT Nears €9.6 Billion Deal to Acquire Molecular Testing Firm Qiagen
The private equity firm is close to finalizing the acquisition of the European molecular testing company, ending years of takeover speculation.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
The story so far
2 publishers have covered this in 2 articles since 21 Oct 2026. Bloomberg Markets published first, on 21 October at 19:38 UTC; News Feed followed 2h 46m later. The most recent article, from News Feed, appeared on 21 October at 22:23 UTC.
Outlets reporting it: Bloomberg Markets (major outlet), News Feed (major outlet).
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- EQT AB
- Qiagen NV